Abstract
IL-33, a new member of the IL-1 cytokine family, may be atheroprotective via induction of a Th1-to-Th2 immunologic switch. However, to date, the role of IL-33 in cardiovascular disease remains unclear. The purpose of this study is to assess the level of IL-33 in atopic patients and its effect on the expression of proteins involved in cholesterol transport.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
